Operating

Deferred Taxes

Eli Lilly Deferred Taxes increased by 97.6% to $1.48B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 277.0%, from $392.00M to $1.48B. Over 3 years (FY 2021 to FY 2024), Deferred Taxes shows an upward trend with a 49.5% CAGR.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalContext dependent
VolatilityVolatile
First reportedQ1 2014
Last reportedQ1 2026

How to read this metric

Positive values indicate tax benefits that improve cash flow, while negative values indicate cash tax outflows exceeding accounting expense.

Detailed definition

This reflects the difference between income tax expense recognized in the financial statements and the actual tax payabl...

Peer comparison

Common across all industries; highly dependent on specific tax jurisdictions and capital expenditure cycles.

Metric ID: deferred_income_taxes

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q4 '25Q1 '26
Value$294.70M$296.00M$92.50M$506.60M$618.40M$1.07B$0.00$559.40M$431.10M$844.30M$506.20M$279.00M$1.01B$429.80M$966.60M$392.00M$1.07B$748.10M$1.48B
QoQ Change+0.4%-68.8%+447.7%+22.1%+73.1%-100.0%-22.9%+95.8%-40.0%-44.9%+261.1%-57.3%+124.9%-59.4%+172.5%-30.0%+97.6%
YoY Change+109.8%+261.7%-100.0%+10.4%-30.3%-21.1%-50.1%+133.7%-49.1%+91.0%+40.5%+6.0%-22.6%+277.0%
Range$0.00$1.48B
CAGR+43.1%
Avg YoY Growth+46.9%
Median YoY Growth+8.2%

Business Segments

View all
SegmentQ4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Reportable Segment$328.55M$293.20M$550.20M$618.10M$628.90M$696.80M$1.12B$1.65B
Total$506.20M$279.00M$1.01B$429.80M$966.60M$392.00M$1.07B

Reportable Segment was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.

Frequently Asked Questions

What is Eli Lilly's deferred taxes?
Eli Lilly (LLY) reported deferred taxes of $1.48B in Q1 2026.
How has Eli Lilly's deferred taxes changed year-over-year?
Eli Lilly's deferred taxes increased by 277.0% year-over-year, from $392.00M to $1.48B.
What is the long-term trend for Eli Lilly's deferred taxes?
Over 3 years (2021 to 2024), Eli Lilly's deferred taxes has grown at a 49.5% compound annual growth rate (CAGR), from $802.30M to $2.68B.
What does deferred taxes mean?
The difference between tax reported on the income statement and actual cash taxes paid.